Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $90
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $77 to $90.
Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $77 to $90.